Asuragen, Focus in diagnostics partnership
This article was originally published in Clinica
Executive Summary
Molecular diagnostics specialist Asuragen has granted non-exclusive worldwide rights for its armoured RNA technology to Focus Diagnostics. The deal will see Focus, the Cypress, California-based infectious disease diagnostics subsidiary of Quest Diagnostics, incorporate Asuragen’s technology into its in vitro molecular diagnostics products. Financial terms of the deal were not revealed. According to Asuragen (Austin, Texas), its armoured RNA technology is designed to package RNA or DNA in baceteriophage coat proteins for protection and stabilisation.